About Us


Founded by three of the world’s leading authorities in neuroscience, medicine and computer science, Mindstrong Health is redefining behavioral healthcare by redefining how care providers will diagnose and manage brain disorders.

Mindstrong’s technology will – for the first time - give patients and providers a seamless and instantaneous method to objectively and continuously measure mood, cognition, and behavior in the home and work environment, delivering insights not possible with traditional clinical, neuropsychological, and imaging techniques.

Mindstrong builds on one of the founder’s digital biomarker platform developed over years of extensive R&D.

Our Values : Science That Makes a Difference.
  • We value curiosity, high quality data, rigorous analysis, innovation
  • We believe that scientific excellence is the foundation for improved diagnostics and therapeutics
  • Our goals are defined by the needs of patients with serious illnesses – we build products for objective measurement but we also attend to subjective experience
Measuring Success: Changing Minds and Fixing brains.
  • Our goals are to reduce disability, hospitalization, ER visits, and suicide
  • We seek to shift healthcare from reactive to proactive
  • Ultimately we will transform care from “diagnose and treat” to “predict and preempt”



Paul Dagum, MD & PhD


Paul Dagum, M.D., Ph.D. is an entrepreneur, scientist and technologist with a track record of creating and launching products in three successful venture-backed companies. Dr. Dagum led NSF and NIH grants while at Stanford University, published over 70 peer-review articles and book chapters in computer science and medicine, and was awarded over 20 patents. Dr. Dagum received an MSc in theoretical physics, PhD in theoretical computer science both from the University of Toronto and an MD from Stanford University.


Tom Insel, MD


Thomas R. lnsel, M.D. is a psychiatrist and neuroscientist.  From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders. Most recently he led the Mental Health Team at Verily. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.


Rick Klausner, MD


Richard D. Klausner is founder and Director of Juno Therapeutics and founder and Director of GRAIL. Dr. Klausner was appointed by Presidents Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development, as well as a past president of the American Society of Clinical Investigation. He is a member of the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences.

Board of Directors

Mindstrong's Board of Directors bring deep experience working at the intersection of academia and industry.

Rick Klausner, MD

Founder and Executive Chairman, Mindstrong Health

Virginia McFerran

President and CEO, Optum Analytics

Tom Insel, MD

Founder and President, Mindstrong Health

CEO and Founder, Foresite Capital

Robert Epstein, MD

CEO, Epstein Health

Paul Dagum, MD PHD

Founder and Chief Executive Officer, Mindstrong Health


Mindstrong’s investors have launched some of the most transformative biotechnology and healthcare companies in neuropsychiatry and neurodegeneration.

Intellectual Property

Mindstrong has developed and patented a biomarker panel that measures brain function from interaction patterns captured passively and continuously from human-computer interfaces found in ubiquitous mobile technology.


Join our Team

Mindstrong Health is building a team of the strongest minds in the business. If youre looking for an exciting career, join the team.